Latest news
Can AstraZeneca (AZN) Reach Its $80 Billion Revenue Goal Despite Clinical Setbacks? - Yahoo Finance UKYahoo Finance UK · Mon, 10 Aug 2026 23:44:03 GMTAstraZeneca, CSPC Pharmaceutical Group establish joint venture in China - BioSpectrum AsiaBioSpectrum Asia · Sun, 09 Aug 2026 17:48:51 GMTAstraZeneca may buck a decade of pharma strategy to buy U.S. scale - CNBCCNBC · Thu, 06 Aug 2026 09:40:16 GMTHow gamification can nudge employees to act more sustainably - Trellis Group (formerly GreenBiz)Trellis Group (formerly GreenBiz) · Wed, 05 Aug 2026 15:16:29 GMT‘No discussions’ ongoing for AstraZeneca-BMS merger: Reuters - Fierce PharmaFierce Pharma · Wed, 05 Aug 2026 14:12:01 GMTExclusive: Pathos AI signs two deals, plans to raise Series E at $3B valuation - Endpoints NewsEndpoints News · Tue, 04 Aug 2026 00:00:00 GMTAstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough - Financial TimesFinancial Times · Mon, 03 Aug 2026 16:33:17 GMTAn AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled. - BioPharma DiveBioPharma Dive · Mon, 03 Aug 2026 16:29:12 GMT